Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jon F. Denissen"'
Autor:
H. L. Sham, Kent D. Stewart, Kennan C. Marsh, Chang H. Park, Thomas Herrin, Xiang-Peng Kong, C. Zhao, Dale J. Kempf, David A. Betebenner, J. J. Plattner, Akhter Molla, T. Robins, D. W. Norbeck, Shuqun Lin, Ayda Saldivar, N. Lyons, Darold L. Madigan, W. Jun. Rosenbrook, Edith McDonald, Jon F. Denissen, Norman Wideburg, Suthida Vasavanonda
Publikováno v:
ChemInform. 27
Autor:
Jon F. Denissen
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 28:1421-1426
Tin mesoporphyrin IX dichloride (Sn-MPCl2) is a heme oxygenase inhibitor of current clinical interest for the treatment of neonatal hyperbilirubinemia. The synthesis of [119mSn]-MPCl2 for drug metabolism and disposition studies is reported. [119mSn]-
Autor:
John M. Leonard, Niu P, G R Granneman, Jon F. Denissen, Akhteruzzaman Molla, G Witt, J Smith, Ann Hsu, N. Lyons, J. Girault, J P Decourt, J B Fourtillan, J Valdes, Keith Erdman, Charles Locke
Publikováno v:
Antimicrobial agents and chemotherapy. 41(5)
The multiple-dose pharmacokinetics of ritonavir were investigated in four groups of human immunodeficiency virus-positive male subjects (with 16 subjects per group) under nonfasting conditions; a 3:1 ritonavir:placebo ratio was used. Ritonavir was gi
Autor:
D W Norbeck, Eugene Sun, John M. Leonard, Dale J. Kempf, Jon F. Denissen, A D Rodrigues, Ann Hsu, Gondi N. Kumar, M J Kukulka, Jacob J. Plattner, Kennan C. Marsh, Edith McDonald, D Pizzuti, P A Baroldi, G R Granneman
Coadministration with the human immunodeficiency virus (HIV) protease inhibitor ritonavir was investigated as a method for enhancing the levels of other peptidomimetic HIV protease inhibitors in plasma. In rat and human liver microsomes, ritonavir po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c984778099e6f40f289d8c2b25bf28ea
https://europepmc.org/articles/PMC163767/
https://europepmc.org/articles/PMC163767/
Autor:
Terrel Robins, Norman E. Wideburg, William Rosenbrook, Ayda Saldivar, Suthida Vasavanonda, Hing L. Sham, Kennan C. Marsh, Kent D. Stewart, Chen Zhao, Jacob J. Plattner, Thomas Herrin, Jon F. Denissen, Nicholas Lyons, Dale J. Kempf, Xiang-P. Kong, David A. Betebenner, Darold L. Madigan, Akhter Molla, Shuqun Lin, Edith McDonald, Chang H. Park, Daniel W. Norbeck
Publikováno v:
Journal of medicinal chemistry. 39(2)
The design, synthesis, and molecular modeling studies of a novel series of azacyclic ureas, which are inhibitors of human immunodeficiency virus type 1 (HIV-1) protease that incorporate different ligands for the S1', S2, and S2' substrate-binding sit
Autor:
Jon F. Denissen
Publikováno v:
Journal of Chromatography A. 462:454-457
Autor:
Jon F. Denissen, Hugh N. Nellans, Robert G. Maki, Joseph F. Dellaria, Francis A. J. Kerdesky, Daniel J. Hoffman
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 27:1437-1450
A synthetic method has been developed for the iterative preparation of unlabelled and 3H-polyethylene glycol (PEG) oligomers. The strategy involved alkylating the sodium anion of mono-tritylated ethylene glycol oligomers (Ph3C[OCH2CH2]nOH, n=1−28)
Publikováno v:
The Journal of Organic Chemistry. 53:2186-2192
Autor:
Marianne K. Johnson, Sudthida Vasavanonda, Hing L. Sham, Dale J. Kempf, Gondi N. Kumar, Daniel W. Norbeck, John M. Leonard, Akhteruzzaman Molla, Jacob J. Plattner, Brian Grabowski, William E. Kohlbrenner, Jon F. Denissen
Publikováno v:
Virology. (2):255-262
The potency of therapeutic regimens containing human immunodeficiency virus (HIV) protease inhibitors is related to the ability to maintain concentrations of drug in the plasma of patients that are sufficient for blocking viral replication. The estim
Publikováno v:
Journal of the American Chemical Society. 109:4399-4401